Health Care & Life Sciences » Biotechnology | Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc. | Balance Sheet

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
129
339
521
347
311
160
Total Accounts Receivable
1
1
1
7
5
6
Inventories
-
-
-
-
2
5
Other Current Assets
5
29
10
4
4
3
Total Current Assets
135
369
532
358
322
173
Net Property, Plant & Equipment
41
1
21
19
18
16
Intangible Assets
98
98
98
98
96
95
Other Assets
-
3
-
-
3
-
Total Assets
651
884
1,066
944
789
289
ST Debt & Current Portion LT Debt
2
20
2
16
14
Accounts Payable
10
13
20
53
58
Other Current Liabilities
8
12
101
95
52
Total Current Liabilities
19
45
123
165
124
Long-Term Debt
20
88
101
85
232
Deferred Taxes
19
19
19
19
6
Other Liabilities
46
36
124
50
23
Total Liabilities
481
600
780
787
737
Common Equity (Total)
170
284
286
157
52
Total Shareholders' Equity
170
284
286
157
52
Total Equity
170
284
286
157
52
Liabilities & Shareholders' Equity
651
884
1,066
944
789

About Lexicon Pharmaceuticals

View Profile
Address
8800 Technology Forest Place
The Woodlands Texas 77381
United States
Employees -
Website http://www.lexpharma.com
Updated 07/08/2019
Lexicon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. It also offers programs in clinical development for diabetes, irritable bowel syndrome, and carcinoid syndrome. The company was founded by Brian P.